<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28079787</article-id>
      <article-id pub-id-type="pmc">5266149</article-id>
      <article-id pub-id-type="publisher-id">MD-D-16-03706</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000005075</article-id>
      <article-id pub-id-type="art-access-id">05075</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>5900</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Oral and vulvo-vaginal lichenoid reactions due to mitotane (Lysodren)</article-title>
        <subtitle>A case report</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Schmouchkovitch</surname>
            <given-names>Arthur</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref rid="cor1" ref-type="corresp">
            <sup>&#x2217;</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Herry</surname>
            <given-names>H&#xE9;lo&#xEF;se</given-names>
          </name>
          <degrees>DDS</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thuillier</surname>
            <given-names>Philippe</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kerlan</surname>
            <given-names>V&#xE9;ronique</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fleuret</surname>
            <given-names>Camille</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Le Toux</surname>
            <given-names>Guy</given-names>
          </name>
          <degrees>DDS, PhD</degrees>
          <xref ref-type="aff" rid="aff4">
            <sup>d</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Boisram&#xE9;</surname>
            <given-names>Sylvie</given-names>
          </name>
          <degrees>DDS, PhD</degrees>
          <xref ref-type="aff" rid="aff4">
            <sup>d</sup>
          </xref>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Zhou.</surname>
            <given-names>Wen</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Department of Dental Surgery</aff>
      <aff id="aff2"><label>b</label>Department of Endocrinology, Brest University Hospital, Brest</aff>
      <aff id="aff3"><label>c</label>Department of Dermatology, Quimper Hospital, Quimper</aff>
      <aff id="aff4"><label>d</label>Department of Oral Surgery, Brest University Hospital, Brest, France.</aff>
      <author-notes id="cor1">
        <corresp><label>&#x2217;</label>Correspondence: Arthur Schmouchkovitch, Department of Dental Surgery, Brest University Hospital, CHRU A. Morvan, 2 rue Auguste Le Faux, 29609 Brest, Cedex, France (e-mail: <email>schmouchkovitch@gmail.com</email>).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>1</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>1</month>
        <year>2017</year>
      </pub-date>
      <volume>96</volume>
      <issue>2</issue>
      <elocation-id>e5075</elocation-id>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>5</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>12</day>
          <month>9</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>9</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2017 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-96-e5075.pdf"/>
      <abstract>
        <title>Abstract</title>
        <sec sec-type="background">
          <title>Background:</title>
          <p>The purpose of pharmacovigilance (drug safety) is collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. It is meant to identify, characterize, prevent, or minimize actual or potential risks relating to medicinal products. To prevent these adverse effects and improve our practice, health professionals have a duty to report side effects to assess this risk and evaluate the benefit/risk requirements. Mitotane (Lysodren) is used for treating adrenocortical carcinoma. Currently, no side effects concerning oral and genital mucosa have been reported.</p>
        </sec>
        <sec>
          <title>Case Summary:</title>
          <p>This case report is about a 50 years old woman. Six months after the initiation on mitotane treatment, she developed erosive lesions located on the oral and vaginal mucosa. These drug reactions were diagnosed as erosive lichen planus by the biopsy. This lichenoid lesions were resistant to the usual treatments, mitotane being at the time not replaceable.</p>
        </sec>
        <sec sec-type="conclusion">
          <title>Conclusion:</title>
          <p>This case describes an unreported adverse effect of mitotane, it is &#x2013; to our knowledge &#x2013; the 1st description of erosive lichenoid drug reaction due to Mitotane.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>case report</kwd>
        <kwd>erosive lichen planus</kwd>
        <kwd>lichenoid lesions</kwd>
        <kwd>lichenoid reactions</kwd>
        <kwd>mitotane</kwd>
        <kwd>side effects</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <label>1</label>
      <title>Introduction</title>
      <p>Adrenocortical carcinoma is a cancer that develops at the expense of the outer layer of the adrenal gland. This is a rare tumor (number of new cases estimated: from 1 to 2 per million populations per year). It occurs most often in adults between 40 and 50 years old but there is also a peak incidence in children under 15 years.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> This tumor is observed most frequently in women. The treatment is complete surgical resection of the tumor, the affected nodes, and any extra adrenal lesion. Medical treatment is considered if incomplete or impossible surgery or even after apparently complete surgery (as adjuvant therapy).<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup></p>
      <p>Mitotane is the generic name of 1,1-dichloro-2-(<italic>o</italic>-chlorophenyl)-2-(<italic>p</italic>-chlorophenyl)-ethane. It is an antineoplastic medication. Mitotane is an adrenal cytotoxic agent. Even if mitotane mechanisms are unknown, it seems that it slows adrenal gland function.<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> It is the only adrenal-specific agent available for the treatment of malignant adrenocortical carcinoma.<sup>[<xref rid="R4" ref-type="bibr">4</xref>&#x2013;<xref rid="R6" ref-type="bibr">6</xref>]</sup></p>
      <p>Oral lichen planus (OLP) is a relatively common chronic mucocutaneous inflammatory disease that affects approximately 0.1% to 2% of the population<sup>[<xref rid="R7" ref-type="bibr">7</xref>]</sup> characterized by a disorder of keratinization, and whose aspects are polymorphic. It can reach the skin, skin appendage, and squamous mucosa (oral, genital, anal, and conjunctival mucosa). It can affect all areas of the oral mucosa but the posterior inferior cheek region represents the elective site. Localized forms are more common than diffuse forms and are frequently bilateral and roughly symmetrical. Pathogenesis is still unclear. Intense stress or anxio-depressive state, diabetes, and hypertension are often reported as trigger factors. OLP could have various etiologies: psychosomatic form, secondary form associated with a general pathology, and secondary form from graft versus host disease.<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R7" ref-type="bibr">7</xref>]</sup> Moreover, &#x201C;induced&#x201D; lichen planus is described and is linked to medicinal or toxic forms. Drug etiology should be sought and eliminated in front of histological lichen planus diagnosis. But interruption of treatment does not necessary conduct to improvement. This &#x201C;lichenoid lesions&#x201D; or &#x201C;lichenoid reactions&#x201D; are clinically and histologically identical to OLP. They can be due to systemic drug or dental restorative materials (gold, mercury, chromium, and copper sulfate).<sup>[<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref>]</sup> Drugs most frequently implicated are nonsteroidal antiinflammatory and angiotensin-converting enzyme inhibitors. Other drugs known to cause this lichenoid reactions include antimalarials, antidepressants, drugs used in treatment of rheumatoid arthritis (gold salts, D-penicillinamine), antihypertensives, diuretics, beta-blockers, hypoglycemic drugs, some antimicrobials, and many others and the list lengthens frequently.<sup>[<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref>]</sup></p>
      <p>To our knowledge, we report the first case of oral and vulvo-vaginal erosive lichenoid eruptions due to mitotane.<sup>[<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R13" ref-type="bibr">13</xref>]</sup></p>
    </sec>
    <sec>
      <label>2</label>
      <title>Case report</title>
      <p>We report the case of a 50 years old woman followed in the Department of Endocrinology at Brest University Hospital (France) for malignant adrenocortical carcinoma.</p>
      <p>In October 2013, the patient came to the emergency department for a superficial phlebitis of the left calf associated with dyspnea. Additional tests revealed a large mass of 6.6&#x200A;cm long axis at the expense of the left adrenal gland. Faced with this suspicion of adrenocortical carcinoma, the patient underwent resective surgery, planned quickly. Pathological analysis confirmed the diagnosis of malignant adrenocortical carcinoma.</p>
      <p>As part of the treatment, the patient received mitotane (Lysodren) as adjuvant treatment. Six months after starting the treatment, she reported severe discomfort at vaginal and oral levels (causing difficulty feeding). An alteration of the mucous membranes was observed. Mitotane treatment also resulted in a central hypothyroidism after 1 year of treatment. This side effect was treated by levothyroxine sodium (Levothyrox). The mensual plasma dosage of mitotane confirmed the stable level of the drug between 14 and 20 nanograms per milliliter, as recommended.</p>
      <p>The initial diagnosis, established in the Endocrinology Department from the clinical data, was an oral candida fungus treated by flucytosine (antifungal for systemic use indicated in severe fungal infections) and fluconazole (antifungal indicated especially in the treatment of candidiasis). Due to lack of efficiency, patient was addressed in the Dermatology Department where a possible lupus was discussed. Immunological tests and vaginal and oral biopsy were performed. A presumptive diagnosis of lichen planus led to corticosteroids mouthwash prescription. Presentation of this case was made in the multidisciplinary lupus consult. This staff concluded that clinical and immunological examinations were not in favor of an induced lupus. The treatment then undertook was mouthwashes of lidocaine (local anesthetic) and prescription of Colchimax (consisting of methyl tiemonium, opium, and colchicine: antigout and antiinflammatory especially indicated to treat Beh&#xE7;et disease). One month later, treatments were suspended because of healing courses of lesions. Investigations have also been undertaken to rule out a deficiency origin. Vitamin supplements were prescribed.</p>
      <p>Finally, biopsy performed at vaginal level revealed an active erosive lichen (Fig. <xref ref-type="fig" rid="F6">6</xref>). Oral biopsy is not specific but by analogy the diagnosis was bipolar erosive lichen planus. The lichen was first treated with corticosteroids (prednisone) that have proven ineffective and badly tolerated by the patient. Then treatment with ciclosporine (Neoral: immunosuppressive therapy) was conducted to the same result. So, prescription of Acitretin (Soriatane: keratolytic agent indicated for the treatment of severe forms of lichen planus on failure of the usual therapeutic) without improvement.</p>
      <p>The patient was sent to the Pathology and Oral Surgery Department of where were objectified:</p>
      <p>Erosive lichenoid lesions on right and left cheeks (Figs. <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Histological section from biopsy, Hematoxylin Eosin Saffron (HES) staining, magnification 200.</p>
        </caption>
        <graphic xlink:href="medi-96-e5075-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Erosive lichenoid eruption on right cheek.</p>
        </caption>
        <graphic xlink:href="medi-96-e5075-g002"/>
      </fig>
      <p>Erosive lichenoid lesion of the right side edge of the tongue (Fig. <xref ref-type="fig" rid="F3">3</xref>).</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Erosive lichenoid eruption on left cheek.</p>
        </caption>
        <graphic xlink:href="medi-96-e5075-g003"/>
      </fig>
      <p>Complicated with pyogenic granuloma on left cheek (Fig. <xref ref-type="fig" rid="F4">4</xref>).</p>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Erosive lichenoid eruption on right side of the tongue.</p>
        </caption>
        <graphic xlink:href="medi-96-e5075-g004"/>
      </fig>
      <p>Erosive lichenoid eruptions associated with endovaginal synechia (Fig. <xref ref-type="fig" rid="F5">5</xref>).</p>
      <fig id="F5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Pyogenic granuloma on left cheek.</p>
        </caption>
        <graphic xlink:href="medi-96-e5075-g005"/>
      </fig>
      <fig id="F6" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Erosive lichenoid eruption with endovaginal synechia.</p>
        </caption>
        <graphic xlink:href="medi-96-e5075-g006"/>
      </fig>
      <p>Now, the patient is treated &#x2013; for its erosive lichen planus &#x2013; by hydroxychloroquine sulfate (Plaquenil: indicated for the treatment of lupus erythematosus and steroid-resistant or refractory lichen planus) associated with corticosteroids mouthwash for OLP and clobetasol propionate (Dermoval) with cortisone for vulvo-vaginal eruptions. At its last consultation, the patient reported significant improvement in both oral and vaginal symptoms.</p>
      <p>Currently, discussion is ongoing to evaluate the benefit/risk balance for the maintenance or not treatment of mitotane, medication being not substitutable at the time.</p>
    </sec>
    <sec>
      <label>3</label>
      <title>Discussion</title>
      <p>Lichenoid lesions correspond to lesions that are clinically and histologically similar to OLP. In contrast of the idiopathic nature of OLP, oral lichenoid lesions are often associated with a known identifiable cause. Lichenoid reactions have been reported after the 2nd world war with the use of antimalarial drugs (mainly quinacrine) then cited by Almeyda and Levantine.<sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup> Since, many substances were associated with these lesions. Serrano-S&#xE0;nchez et al (2010)<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup> proposed a review of the literature of different drugs that may cause these lichenoid reactions. We completed this review and proposed a table with different drugs incriminated in oral lichenoid lesions (Table <xref ref-type="table" rid="T1">1</xref>). It may be noted that 20% to 25% of women with oral lichen planus have vulvovaginal involvement, generally in erosive or desquamative form.</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Lichenoid drug reactions in literature.</p>
        </caption>
        <graphic xlink:href="medi-96-e5075-g007"/>
      </table-wrap>
      <p>The etiology and pathogenesis of lichen planus is still unknown. Latest hypothesis refers to a probable genetic background and an autoimmune action with a lymphotoxicity reaction against basal membrane. Some factors are associated with the disease: autoimmune disorders (such as chronic active hepatitis, ulcerative colitis), diabetes and hypertension, stress and anxiety, trauma, food allergies, habits like cigarettes or betel nut chewing, malignant neoplasms, bowel disease and more commonly infectious agents (such as <italic>Helicobacter pilori</italic>, Epstein&#x2013;Barr virus, human herpes virus 6, human immunodeficiency virus, and hepatitis C), and drugs.<sup>[<xref rid="R65" ref-type="bibr">65</xref>]</sup> For didactic purposes, an updated table of lichenoid drug reactions is proposed (Table <xref ref-type="table" rid="T1">1</xref>).</p>
      <p>To our knowledge, this is the first reported case on oral and vaginal lichenoid reactions due to mitotane. Mitotane is known to cause various skin rashes but no cases of oral or genital erosive eruption had been described. The biochemical mechanism of mitotane is unknown. It has not been studied in a clinical development program. The available clinical data are largely derived from published data in patients with inoperable or metastatic adrenal carcinoma. In terms of overall survival, 4 studies concluded that mitotane does not increase the survival rate, while 5 reported an increase survival rate.<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R66" ref-type="bibr">66</xref>&#x2013;<xref rid="R68" ref-type="bibr">68</xref>]</sup> Available data suggest that mitotane modifies the peripheral metabolism of steroids by directly suppressing secretion of the adrenal cortex. The administration of mitotane alters the extra-adrenal metabolism in humans, leading to a decline of measurable 17-hydroxy corticosteroids, even without decrease in plasma corticosteroids. Mitotane apparently causes increased formation of 6-beta-hydroxy cholesterol.<sup>[<xref rid="R69" ref-type="bibr">69</xref>]</sup> Recent studies showed that mitotane directly interacts with lipid membranes by intercalation of mitotane into phospholipidic bilayers impacting on membrane.<sup>[<xref rid="R70" ref-type="bibr">70</xref>]</sup> The most common side effects are gastrointestinal disorders (inflammation of the lining, vomiting, diarrhea, nausea, and epigastric discomfort), neurological side effects (ataxia, paraesthesia, dizziness, drowsiness, mental impairment, polyneuropathy, motor disorder, headache, and confusion), hematological and lymphatic disorders (leukopenia, prolonged bleeding time), musculoskeletal disorders (myasthenia gravis), metabolic and nutritional disorders (anorexia, hypercholesterolemia, and central hypothyroidism),<sup>[<xref rid="R71" ref-type="bibr">71</xref>]</sup> general disorders (asthenia), and as conditions of the skin and subcutaneous tissue (skin rash). Lesions linked to lichen planus have been described in cutaneous<sup>[<xref rid="R72" ref-type="bibr">72</xref>]</sup> level but not on the oral and genital mucosa.</p>
      <p>Typically the treatment of these lesions involves stopping the substance. A therapeutic window has been considered in consultation with the Department of Endocrinology in order to highlight the correlation between mitotane and erosive lesions. However, mitotane still irreplaceable at this time for the management of malignant adrenocortical carcinoma. This constitutes a limitation of this ascertainment.</p>
      <p>After various consultations (endocrinology, dermatology, and oral pathology), probable diagnosis was eliminated in favor of bipolar erosive lichen planus in connection with mitotane introduction 6 months before. Other explanations were eluded. In fact, paraneoplastic lesion was eliminated by anatomopathological exam. Contact dermatitis has been removed by the dermatologist. In addition, idiopathic origin would not have been refractory to treatment.</p>
      <p>This patient is under antihypertensive therapy since several years. But mitotane was the only new drug introduced prior to lichenoid reactions development. Moreover a case of cutaneous lichen linked to mitotane has previously been reported in the literature.</p>
      <p>This presents real challenges for the care of the patient regarding her life comfort, as far these lichenoid reactions were resistant to all therapeutics implemented. However, an improvement was observed with treatment by hydroxychloroquine sulfate (Plaquenil) efficacy already observed in 1993 by Eisen in an open trial conducted with ten patients who had biopsy-proven OLP.<sup>[<xref rid="R73" ref-type="bibr">73</xref>]</sup></p>
    </sec>
    <sec>
      <label>4</label>
      <title>Informed consent</title>
      <p>The patient gave her consent to publish this case report.</p>
    </sec>
    <sec>
      <label>5</label>
      <title>Conclusion</title>
      <p>Mitotane should now be registered in the list of substances causing lichenoid lesions on oral and vaginal mucosa. This first case report should be known by medical population (endocrinologists, dermatologists, oral, and dental surgeons) to improve the therapeutic care.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="abbr">
        <p>Abbreviation: OLP = oral lichen planus.</p>
      </fn>
      <fn fn-type="COI-statement">
        <p>The authors have no funding and conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>[1]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wooten</surname><given-names>MD</given-names></name><name><surname>King</surname><given-names>DK</given-names></name></person-group>
<article-title>Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature</article-title>. <source>Cancer</source>
<year>1993</year>;<volume>72</volume>:<fpage>3145</fpage>&#x2013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">8242539</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>[2]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allolio</surname><given-names>B</given-names></name><name><surname>Fassnacht</surname><given-names>M</given-names></name></person-group>
<article-title>Clinical review: adrenocartical carcinoma: clinical update</article-title>. <source>J Clin Endocrinol Metab</source>
<year>2006</year>;<volume>91</volume>:<fpage>2027</fpage>&#x2013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">16551738</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>[3]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seintou</surname><given-names>A</given-names></name><name><surname>Gaydarov</surname><given-names>N</given-names></name><name><surname>Lombardi</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Oral lichen planus and malignant transformation: part II: 6 cases report</article-title>. <source>Med Buccale Chir Buccale</source>
<year>2012</year>;<volume>18</volume>:<fpage>235</fpage>&#x2013;<lpage>50</lpage>.</mixed-citation>
      </ref>
      <ref id="R4">
        <label>[4]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postlewait</surname><given-names>LM</given-names></name><name><surname>Ethun</surname><given-names>CG</given-names></name><name><surname>Tran</surname><given-names>TB</given-names></name><etal/></person-group>
<article-title>Outcomes of adjuvant mitotane after resection of adrenocortical carcinoma: a 13-institution study by the US Adrenocortical Carcinoma Group</article-title>. <source>J Am Coll Surg</source>
<year>2016</year>;<volume>222</volume>:<fpage>480</fpage>&#x2013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">26775162</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>[5]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wooten</surname><given-names>MD</given-names></name><name><surname>King</surname><given-names>DK</given-names></name></person-group>
<article-title>Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature</article-title>. <source>Cancer</source>
<year>1993</year>;<volume>72</volume>:<fpage>3145</fpage>&#x2013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">8242539</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>[6]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luton</surname><given-names>JP</given-names></name><name><surname>Cerdas</surname><given-names>S</given-names></name><name><surname>Billaud</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy</article-title>. <source>N Engl J Med</source>
<year>1991</year>;<volume>322</volume>:<fpage>1195</fpage>&#x2013;<lpage>201</lpage>.</mixed-citation>
      </ref>
      <ref id="R7">
        <label>[7]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chbicheb</surname><given-names>S</given-names></name><name><surname>El Wady</surname><given-names>W</given-names></name></person-group>
<article-title>Lichen plan buccal</article-title>. <source>EMC - M&#xE9;decine buccale</source>
<year>2008</year>;<fpage>1</fpage>&#x2013;<lpage>5</lpage>. <comment>[Article 28-285-G-10]</comment>.</mixed-citation>
      </ref>
      <ref id="R8">
        <label>[8]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Issa</surname><given-names>Y</given-names></name><name><surname>Buxbury</surname><given-names>AJ</given-names></name><name><surname>Macfarlane</surname><given-names>TV</given-names></name><etal/></person-group>
<article-title>Oral lichenoid l&#xE9;sions related to dental rstorative materials</article-title>. <source>Brit Dent J</source>
<year>2005</year>;<volume>198</volume>:<fpage>361</fpage>&#x2013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">15789104</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>[9]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>P</given-names></name><name><surname>Bahmer</surname><given-names>FA</given-names></name></person-group>
<article-title>Oral lesions and symptoms related to metals used in dental restorations: a clinical, allergological, and histologic study</article-title>. <source>J Am Acad Dermatol</source>
<year>1999</year>;<volume>41</volume>:<fpage>422</fpage>&#x2013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">10459117</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>[10]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>DF</given-names></name><name><surname>Skaehill</surname><given-names>PA</given-names></name></person-group>
<article-title>Drug-induced lichen planus</article-title>. <source>Pharmacotherapy</source>
<year>1994</year>;<volume>14</volume>:<fpage>561</fpage>&#x2013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">7997389</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>[11]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirota</surname><given-names>SK</given-names></name><etal/></person-group>
<article-title>Analysis of a possible association between oral lichen planus and drug intake. A control study</article-title>. <source>Med Oral Patol Oral Cir Bucal</source>
<year>2011</year>;<volume>16</volume>:<fpage>e750</fpage>&#x2013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">21196843</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>[12]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeyda</surname><given-names>J</given-names></name><name><surname>Levantine</surname><given-names>A</given-names></name></person-group>
<article-title>Drug reactions XVI. Lichenoid drug eruptions</article-title>. <source>Br J Dermatol</source>
<year>1971</year>;<volume>85</volume>:<fpage>604</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">4259599</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>[13]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serrano-S&#xE0;nchez</surname><given-names>P</given-names></name><name><surname>Bag&#xE0;n</surname><given-names>JV</given-names></name><name><surname>Jim&#xE9;nez-Soriano</surname></name><etal/></person-group>
<article-title>Drug-induced lichenoid reactions. A literature review</article-title>. <source>J Clin Exp Dent</source>
<year>2010</year>;<volume>2</volume>:<fpage>e71</fpage>&#x2013;<lpage>5</lpage>.</mixed-citation>
      </ref>
      <ref id="R14">
        <label>[14]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potts</surname><given-names>AJ</given-names></name></person-group>
<article-title>The medication of patients with oral lichen planus and the association of nonsteroidal anti-inflammatory drugs with erosive lesions</article-title>. <source>Oral Surg Oral Med Oral Pathol</source>
<year>1987</year>;<volume>64</volume>:<fpage>541</fpage>&#x2013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">3478637</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>[15]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>SC</given-names></name></person-group>
<article-title>Drug eruption</article-title>. <source>Br J Dermatol</source>
<year>1966</year>;<volume>78</volume>:<fpage>549</fpage>&#x2013;<lpage>50</lpage>.</mixed-citation>
      </ref>
      <ref id="R16">
        <label>[16]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#xFC;nes</surname><given-names>AT</given-names></name><etal/></person-group>
<article-title>Naproxen-induced lichen planus: report of 55 cases</article-title>. <source>Int J Dermatol</source>
<year>2006</year>;<volume>45</volume>:<fpage>709</fpage>&#x2013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">16796633</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>[17]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bag&#xE1;n</surname><given-names>JV</given-names></name></person-group>
<article-title>Adverse oral reactions associated with the COX-2 inhibitor rofecoxib</article-title>. <source>Oral Dis</source>
<year>2004</year>;<volume>10</volume>:<fpage>401</fpage>&#x2013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">15533219</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>[18]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firth</surname><given-names>NA</given-names></name></person-group>
<article-title>Angiotensin-converting enzyme inhibitors implicated in oral mucosal lichenoid reactions</article-title>. <source>Oral Surg Oral Med Oral Pathol</source>
<year>1989</year>;<volume>67</volume>:<fpage>41</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">2536146</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>[19]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>J</given-names></name></person-group>
<article-title>Lichenoid dermatitis due to chloroquine</article-title>. <source>Br J Dermatol</source>
<year>1958</year>;<volume>70</volume>:<fpage>181</fpage>.<pub-id pub-id-type="pmid">13536249</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>[20]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutler</surname><given-names>TP</given-names></name></person-group>
<article-title>Lichen planus caused by pyrimethamine</article-title>. <source>Clin Exp Dermatol</source>
<year>1980</year>;<volume>5</volume>:<fpage>253</fpage>&#x2013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">6449324</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>[21]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazemore</surname><given-names>JM</given-names></name><name><surname>Johnson</surname><given-names>HH</given-names></name><etal/></person-group>
<article-title>Relation to quinacrine hydrochloride to lichenoid dermatitis (atypical lichen planus)</article-title>. <source>Arch Derm Syphilol</source>
<year>1946</year>;<volume>54</volume>:<fpage>308</fpage>&#x2013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">20996826</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>[22]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zain</surname><given-names>RB</given-names></name></person-group>
<article-title>Oral lichenoid reactions during antimalarial prophylaxis with sulphadoxine-pyrimethamine combination</article-title>. <source>Southest Asian J Trop Med Public Health</source>
<year>1989</year>;<volume>20</volume>:<fpage>253</fpage>&#x2013;<lpage>6</lpage>.</mixed-citation>
      </ref>
      <ref id="R23">
        <label>[23]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martkitziu</surname><given-names>A</given-names></name></person-group>
<article-title>Lichenoid lesions of oral mucosa associated with ketoconazole</article-title>. <source>Mycoses</source>
<year>1986</year>;<volume>29</volume>:<fpage>317</fpage>&#x2013;<lpage>22</lpage>.</mixed-citation>
      </ref>
      <ref id="R24">
        <label>[24]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaomongkolgit</surname><given-names>R</given-names></name></person-group>
<article-title>Oral lichenoid drug reaction associated with antihypertensive and hypoglycemic drugs</article-title>. <source>J Drugs Dermatol</source>
<year>2010</year>;<volume>9</volume>:<fpage>73</fpage>&#x2013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">20120430</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>[25]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>CJ</given-names></name></person-group>
<article-title>Lichenoid eruptions due to methyldopa</article-title>. <source>Br J Dermatol</source>
<year>1971</year>;<volume>85</volume>:<fpage>600</fpage>.<pub-id pub-id-type="pmid">5145426</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>[26]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burry</surname><given-names>JN</given-names></name><name><surname>Kirk</surname><given-names>J</given-names></name></person-group>
<article-title>Lichenoid drug reaction from methyldopa</article-title>. <source>Br J Dermatol</source>
<year>1974</year>;<volume>91</volume>:<fpage>475</fpage>&#x2013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">4425629</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>[27]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname><given-names>KD</given-names></name><name><surname>Reade</surname><given-names>PC</given-names></name></person-group>
<article-title>Methyldopa as a cause of oral mucous membrane reactions</article-title>. <source>Br Dent J</source>
<year>1978</year>;<volume>145</volume>:<fpage>195</fpage>&#x2013;<lpage>203</lpage>.<pub-id pub-id-type="pmid">279340</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>[28]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>SL</given-names></name></person-group>
<article-title>Lichenoid reaction of oral mucosa and skin to methyldopa</article-title>. <source>J Oral Med</source>
<year>1982</year>;<volume>37</volume>:<fpage>42</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">6213747</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>[29]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiesenfeld</surname><given-names>D</given-names></name><name><surname>Scully</surname><given-names>C</given-names></name><name><surname>Mac Fayden</surname><given-names>EE</given-names></name></person-group>
<article-title>Multiple lichenoide drug reactions in a patient with Ferguson Smith disease</article-title>. <source>Oral Surg Oral Med Oral Pathol</source>
<year>1982</year>;<volume>54</volume>:<fpage>527</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">6960307</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>[30]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felix</surname><given-names>RH</given-names></name><name><surname>Ive</surname><given-names>FA</given-names></name><name><surname>Dahl</surname><given-names>MG</given-names></name></person-group>
<article-title>Cutaneous and ocular reactions to practolol</article-title>. <source>Br Med J</source>
<year>1974</year>;<volume>4</volume>:<fpage>321</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">4279720</pub-id></mixed-citation>
      </ref>
      <ref id="R31">
        <label>[31]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawk</surname><given-names>JL</given-names></name></person-group>
<article-title>Lichenoid drug eruption induced by propanolol</article-title>. <source>Clin Exp Dermatol</source>
<year>1980</year>;<volume>5</volume>:<fpage>93</fpage>&#x2013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">7398132</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>[32]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakshmi</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Perforating lichenoid reaction to amlodipine</article-title>. <source>Indian J Dermatol</source>
<year>2008</year>;<volume>53</volume>:<fpage>98</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">19882000</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>[33]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>S</given-names></name></person-group>
<article-title>Cutaneous side-effects of beta-adrenergic blockers</article-title>. <source>Australas J Dermatol</source>
<year>1985</year>;<volume>26</volume>:<fpage>25</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">2865950</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>[34]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhyayai</surname><given-names>JB</given-names></name><etal/></person-group>
<article-title>Cutaneous reactions due to antihypertensive drugs</article-title>. <source>Indian J Dermatol</source>
<year>2006</year>;<volume>51</volume>:<fpage>189</fpage>&#x2013;<lpage>91</lpage>.</mixed-citation>
      </ref>
      <ref id="R35">
        <label>[35]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shatin</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Lichen planus-like drug eruption due to para-amino salicylic acid; report of 5 cases, two showing mouth lesions</article-title>. <source>J Invest Dermatol</source>
<year>1953</year>;<volume>21</volume>:<fpage>135</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">13084978</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>[36]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronny</surname><given-names>AT</given-names></name><etal/></person-group>
<article-title>Oral mucosal lichenoid reaction to sulfamethoxazole</article-title>. <source>Spec Care Dentist</source>
<year>1990</year>;<volume>10</volume>:<fpage>55</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">11100207</pub-id></mixed-citation>
      </ref>
      <ref id="R37">
        <label>[37]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>MM</given-names></name><etal/></person-group>
<article-title>Oral mucosal lichenoid eruption due to fenclofenac</article-title>. <source>J Oral Med</source>
<year>1984</year>;<volume>39</volume>:<fpage>39</fpage>&#x2013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">6232357</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>[38]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seehafer</surname><given-names>JR</given-names></name><etal/></person-group>
<article-title>Lichen planus-like lesions caused by penicillamine in primary biliary cirrhosis</article-title>. <source>Arch Dermatol</source>
<year>1981</year>;<volume>117</volume>:<fpage>140</fpage>&#x2013;<lpage>2</lpage>.<pub-id pub-id-type="pmid">6452095</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>[39]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blasberg</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Lichenoid lesions of the oral mucosa in rheumatoid arthritis patients treated with penicillamine</article-title>. <source>J Rheumatol</source>
<year>1984</year>;<volume>11</volume>:<fpage>348</fpage>&#x2013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">6737375</pub-id></mixed-citation>
      </ref>
      <ref id="R40">
        <label>[40]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>RS</given-names></name><etal/></person-group>
<article-title>Treatment of gold salt-induced lichen planus: report of a case</article-title>. <source>Cutis</source>
<year>1993</year>;<volume>51</volume>:<fpage>183</fpage>&#x2013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">8444050</pub-id></mixed-citation>
      </ref>
      <ref id="R41">
        <label>[41]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinsdale</surname><given-names>RC</given-names></name></person-group>
<article-title>Lichenoid eruption due to chlorpropamide</article-title>. <source>Br Med J</source>
<year>1968</year>;<volume>1</volume>:<fpage>100</fpage>.<pub-id pub-id-type="pmid">5634694</pub-id></mixed-citation>
      </ref>
      <ref id="R42">
        <label>[42]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aframian</surname><given-names>DJ</given-names></name></person-group>
<article-title>Oral adverse effects for escitalopram (Cipralex)</article-title>. <source>Br J Dermatol</source>
<year>2007</year>;<volume>156</volume>:<fpage>1046</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">17326749</pub-id></mixed-citation>
      </ref>
      <ref id="R43">
        <label>[43]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colvard</surname><given-names>MD</given-names></name></person-group>
<article-title>Ativan (lorazepam) induced lichenoid reaction of the human attached gingiva: case report</article-title>. <source>Periodontal Case Rep</source>
<year>1986</year>;<volume>8</volume>:<fpage>69</fpage>&#x2013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">3470822</pub-id></mixed-citation>
      </ref>
      <ref id="R44">
        <label>[44]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Torres</surname><given-names>R</given-names></name><name><surname>Almagro</surname><given-names>M</given-names></name><name><surname>del Pozo</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Lichenoid drug eruption induced by olanzapine</article-title>. <source>Actas Dermosifiliogr</source>
<year>2008</year>;<volume>99</volume>:<fpage>221</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">18358199</pub-id></mixed-citation>
      </ref>
      <ref id="R45">
        <label>[45]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>DJ</given-names></name><etal/></person-group>
<article-title>Lichenoid stomatitis associated with lithium carbonate</article-title>. <source>J Am Acad Dermatol</source>
<year>1985</year>;<volume>13</volume><issue>(2 Pt 1)</issue>:<fpage>243</fpage>&#x2013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">3930581</pub-id></mixed-citation>
      </ref>
      <ref id="R46">
        <label>[46]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campisi</surname><given-names>G</given-names></name></person-group>
<article-title>Oral lichenoid drug reaction by lithium in a patient with bipolar disorder</article-title>. <source>J Oral Pathol Med</source>
<year>2005</year>;<volume>34</volume>:<fpage>124</fpage>&#x2013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">15641994</pub-id></mixed-citation>
      </ref>
      <ref id="R47">
        <label>[47]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascual</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases</article-title>. <source>Int J Dermatol</source>
<year>2006</year>;<volume>45</volume>:<fpage>1471</fpage>&#x2013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">17184272</pub-id></mixed-citation>
      </ref>
      <ref id="R48">
        <label>[48]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ena</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Oral lichenoid eruption secondary to imatinib (Glivec)</article-title>. <source>J Dermatolog Treat</source>
<year>2004</year>;<volume>15</volume>:<fpage>253</fpage>&#x2013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">15764042</pub-id></mixed-citation>
      </ref>
      <ref id="R49">
        <label>[49]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>DS</given-names></name><name><surname>Muir</surname><given-names>J</given-names></name></person-group>
<article-title>Oral lichenoid reaction to imatinib (STI 571, Gleevec)</article-title>. <source>Dermatology</source>
<year>2002</year>;<volume>205</volume>:<fpage>169</fpage>&#x2013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">12218235</pub-id></mixed-citation>
      </ref>
      <ref id="R50">
        <label>[50]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chau</surname><given-names>NY</given-names></name><etal/></person-group>
<article-title>Allopurinol-amplified lichenoid reactions of the oral mucosa</article-title>. <source>Oral Surg Oral Med Oral Pathol</source>
<year>1984</year>;<volume>58</volume>:<fpage>397</fpage>&#x2013;<lpage>400</lpage>.<pub-id pub-id-type="pmid">6593665</pub-id></mixed-citation>
      </ref>
      <ref id="R51">
        <label>[51]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>H</given-names></name></person-group>
<article-title>Lichenoid eruption due to Amiphenazole</article-title>. <source>Br J Dermatol</source>
<year>1964</year>;<volume>76</volume>:<fpage>186</fpage>&#x2013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">14140743</pub-id></mixed-citation>
      </ref>
      <ref id="R52">
        <label>[52]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajnsek</surname><given-names>S</given-names></name></person-group>
<article-title>Lichen planus induced by carbamazepine: a case report</article-title>. <source>Epilepsy Behav</source>
<year>2012</year>;<volume>24</volume>:<fpage>269</fpage>&#x2013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">22564889</pub-id></mixed-citation>
      </ref>
      <ref id="R53">
        <label>[53]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrelo</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Lichen planus-like eruption with esophageal involvement as a result of cyanamide</article-title>. <source>J Am Acad Dermatol</source>
<year>1990</year>;<volume>23</volume><issue>(6 Pt 1)</issue>:<fpage>1168</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">2273123</pub-id></mixed-citation>
      </ref>
      <ref id="R54">
        <label>[54]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawana</surname><given-names>S</given-names></name></person-group>
<article-title>Drug eruption induced by cyanamide (carbimide): a clinical and histopathologic study of 7 patients</article-title>. <source>Dermatology</source>
<year>1997</year>;<volume>195</volume>:<fpage>30</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">9267733</pub-id></mixed-citation>
      </ref>
      <ref id="R55">
        <label>[55]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirby</surname><given-names>JD</given-names></name></person-group>
<article-title>Levamisole-induced lichenoid eruptions</article-title>. <source>J R Soc Med</source>
<year>1980</year>;<volume>73</volume>:<fpage>208</fpage>&#x2013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">6453230</pub-id></mixed-citation>
      </ref>
      <ref id="R56">
        <label>[56]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groth</surname><given-names>O</given-names></name></person-group>
<article-title>Lichenoid dermatitis resulting from treatment with the phenothiazine derivatives metopromazine and laevomepromazine</article-title>. <source>Acta Derm Venereol</source>
<year>1961</year>;<volume>41</volume>:<fpage>168</fpage>&#x2013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">13709129</pub-id></mixed-citation>
      </ref>
      <ref id="R57">
        <label>[57]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishibashi</surname><given-names>A</given-names></name><name><surname>Hirano</surname><given-names>K</given-names></name><name><surname>Nishiyama</surname><given-names>Y</given-names></name></person-group>
<article-title>Photosensitive dermatisis due to pyritinol</article-title>. <source>Arch Dermatol</source>
<year>1973</year>;<volume>107</volume>:<fpage>427</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">4266310</pub-id></mixed-citation>
      </ref>
      <ref id="R58">
        <label>[58]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guijarro</surname><given-names>B</given-names></name></person-group>
<article-title>Lichenoid reaction caused by Clopidogrel, a new anti-platelet drug</article-title>. <source>Med Oral</source>
<year>2003</year>;<volume>8</volume>:<fpage>33</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">12556721</pub-id></mixed-citation>
      </ref>
      <ref id="R59">
        <label>[59]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simone</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Lichenoid reaction induced by adalimumab</article-title>. <source>J Eur Acad Dermatol Venereol</source>
<year>2008</year>;<volume>22</volume>:<fpage>626</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">18005023</pub-id></mixed-citation>
      </ref>
      <ref id="R60">
        <label>[60]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pemberton</surname><given-names>MN</given-names></name><etal/></person-group>
<article-title>Oral lichenoid lesions after hepatitis B vaccination</article-title>. <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
<year>2000</year>;<volume>89</volume>:<fpage>717</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">10846126</pub-id></mixed-citation>
      </ref>
      <ref id="R61">
        <label>[61]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armour</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Complicated lichenoid drug eruption</article-title>. <source>Australas J Dermatol</source>
<year>2005</year>;<volume>46</volume>:<fpage>21</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">15670173</pub-id></mixed-citation>
      </ref>
      <ref id="R62">
        <label>[62]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giuliani</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Oral lichenoid lesions in HIV-HCV-coinfected subjects during antiviral therapy: 2 cases and review of the literature</article-title>. <source>Am J Dermatopathol</source>
<year>2008</year>;<volume>30</volume>:<fpage>466</fpage>&#x2013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">18806491</pub-id></mixed-citation>
      </ref>
      <ref id="R63">
        <label>[63]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azzam</surname><given-names>H</given-names></name></person-group>
<article-title>Lichen planus associated with metformin therapy</article-title>. <source>Dermatology</source>
<year>1997</year>;<volume>194</volume>:<fpage>376</fpage>.<pub-id pub-id-type="pmid">9252768</pub-id></mixed-citation>
      </ref>
      <ref id="R64">
        <label>[64]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Mucosal (oral and vulvar) lichen planus in women: are angiotensin-converting inhibitors protective, and beta-blockers and non-steroidal anti-inflammatory drugs associated with the condition?</article-title>
<source>Clin Exp Dermatol</source>
<year>2010</year>;<volume>35</volume>:<fpage>384</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">19874335</pub-id></mixed-citation>
      </ref>
      <ref id="R65">
        <label>[65]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Jawanda</surname><given-names>MK</given-names></name></person-group>
<article-title>Oral lichen planus: an update on etiology, pathogenesis, clinical presentation, diagnosis and management</article-title>. <source>India J Dermatol</source>
<year>2015</year>;<volume>60</volume>:<fpage>222</fpage>&#x2013;<lpage>9</lpage>.</mixed-citation>
      </ref>
      <ref id="R66">
        <label>[66]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guelho</surname><given-names>D</given-names></name><name><surname>Paiva</surname><given-names>I</given-names></name><name><surname>Vieira</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Adrenocortical carcinoma: retrospective analysis of the last 22 years</article-title>. <source>Endocrinol Nutr</source>
<year>2016</year>;<volume>63</volume>:<fpage>212</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">26969077</pub-id></mixed-citation>
      </ref>
      <ref id="R67">
        <label>[67]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>MC</given-names></name><name><surname>Tan</surname><given-names>YO</given-names></name><name><surname>Chong</surname><given-names>PY</given-names></name><etal/></person-group>
<article-title>Treatment of adrenal cortical carcinoma with mitotane: outcome and complications</article-title>. <source>Ann Acad Med Singapore</source>
<year>1990</year>;<volume>19</volume>:<fpage>540</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">2171414</pub-id></mixed-citation>
      </ref>
      <ref id="R68">
        <label>[68]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downing</surname><given-names>V</given-names></name><name><surname>Eule</surname><given-names>J</given-names></name><name><surname>Huseby</surname><given-names>RA</given-names></name></person-group>
<article-title>Regression of an adrenal cortical carcinoma and its neovascular bed following mitotane therapy: a case report</article-title>. <source>Cancer</source>
<year>1974</year>;<volume>34</volume>:<fpage>1882</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">4434322</pub-id></mixed-citation>
      </ref>
      <ref id="R69">
        <label>[69]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sbiera</surname><given-names>S</given-names></name><name><surname>Leich</surname><given-names>E</given-names></name><name><surname>Liebisch</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Mitotane inhibits sterol-O-acyl transferase 1 triggering lipid-mediated endoplasmic reticulum stress and apoptosis in adrenocortical carcinoma cells</article-title>. <source>Endocrinology</source>
<year>2015</year>;<volume>156</volume>:<fpage>3895</fpage>&#x2013;<lpage>908</lpage>.<pub-id pub-id-type="pmid">26305886</pub-id></mixed-citation>
      </ref>
      <ref id="R70">
        <label>[70]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheidt</surname><given-names>HA</given-names></name><name><surname>Haralampiev</surname><given-names>I</given-names></name><name><surname>Theisgen</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>The adrenal specific toxicant mitotane directly interacts with lipid membranes and alters membrane properties depending on lipid composition</article-title>. <source>Mol Cell Endocrinol</source>
<year>2016</year>;<volume>428</volume>:<fpage>68</fpage>&#x2013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">27002491</pub-id></mixed-citation>
      </ref>
      <ref id="R71">
        <label>[71]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>M</given-names></name><name><surname>Scollo</surname><given-names>C</given-names></name><name><surname>Pellegriti</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism</article-title>. <source>Clin Endocrinol (Oxf)</source>
<year>2016</year>;<volume>84</volume>:<fpage>614</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">26221968</pub-id></mixed-citation>
      </ref>
      <ref id="R72">
        <label>[72]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuehlke</surname><given-names>RL</given-names></name></person-group>
<article-title>Erythematous eruption of the palms and soles associated with mitotane therapy</article-title>. <source>Dermatologica</source>
<year>1974</year>;<volume>148</volume>:<fpage>90</fpage>&#x2013;<lpage>2</lpage>.<pub-id pub-id-type="pmid">4276191</pub-id></mixed-citation>
      </ref>
      <ref id="R73">
        <label>[73]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisen</surname><given-names>D</given-names></name></person-group>
<article-title>Hydroxychloroquine Sulfate (Plaquenil) improves oral lichen planus: an open trial</article-title>. <source>J Am Acad Dermatol</source>
<year>1993</year>;<volume>28</volume>:<fpage>609</fpage>&#x2013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">8463463</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
